PARI Acquires Nortev, Maker of Equine Inhaler Flexineb

PARI, manufacturer of medical devices and pharmaceuticals in the field of respiratory and inhalation, has acquired Irish company Nortev. Nortev manufactures and sells the equine nebulizer Flexineb^®, a device for respiratory therapy in horses by nebulizing medication or saline. In addition, Nortev also offers nebulization devices for companion animals.

Since its founding in 2008 in Galway, Ireland, Nortev has become a leading manufacturer of nebulizers for horses and companion animals and distributes its products worldwide to more than 30 countries in Europe, North America, Australia and the Middle East. Customers include well-known veterinary clinics, horse studs, horse trainers as well as professional and leisure riders.

PARI CEO Arne W. Dirks said, “Our goal is to establish PARI’s more than 100 years of experience in inhalation therapy in the field of animal inhalation. With Nortev we have found a company that, like us at PARI, develops and sells innovative inhalation devices with the highest quality standards. Together, we can develop new inhalation therapies that benefit horses and small animals with respiratory diseases – and thus also their owners.”

Nortev will continue to be run as an independent company by the two founders Gavan O’Sullivan and Declan Moran. “I look forward to further developing our Flexineb^® equine nebulizer under the PARI umbrella,” said Nortev CEO and Managing Director Gavan O’Sullivan. “There will be no changes for our Flexineb^® customers as a result of the acquisition. With PARI’s support, we will enhance our core vision of continuous improvement and innovation in animal respiratory healthcare.”

The takeover of Nortev is the first acquisition under PARI’s growth and diversification strategy driven by its CEO Arne W. Dirks, through which PARI is gaining access to a promising market. In addition, it opens attractive synergy potential.